|Publication number||US3906950 A|
|Publication date||23 Sep 1975|
|Filing date||2 Apr 1974|
|Priority date||4 Apr 1973|
|Also published as||DE2415961A1, DE7411543U|
|Publication number||US 3906950 A, US 3906950A, US-A-3906950, US3906950 A, US3906950A|
|Original Assignee||Isf Spa|
|Export Citation||BiBTeX, EndNote, RefMan|
|Patent Citations (7), Referenced by (257), Classifications (8)|
|External Links: USPTO, USPTO Assignment, Espacenet|
tinited States @ocozza 1 INHALING DEVICE FOR POWDERED MEDICAMENTS  lnventor: Salvatore Cocozza, Milan, Italy [73} Assignee: I.S.F. S.p.A., Milan, ltaly  Filed: Apr. 2, 1974  Appl. No.: 457,270
 Foreign Application Priority Data Apr. 4, 1973 Italy 22576/73 June 22, 1973 Italy; 25698/73  US. Cl. 128/266; 128/206  Int. Cl. A61M 13/00; A61M 15/08  Field of Search 128/266, 206, 208, 194, 128/265  References Cited UNITED STATES PATENTS 2,307,986 l/1943 Bolt et al. 128/266 so ,2 20* y 2,517,482 8/1950 Hall 128/206 2,519,555 8/1950 128/266 2,581,182 l/1952 128/206 2,946,332 7/1960 Sacks 128/266 3507277 4/1970 Altounyan et al 128/208 3,669,113 6/1972 Altounyan et a1. 128/266 Primary Examiner-Aldrich F. Medbery Attorney, Agent, or Firm-Depaoli & OBrien  ABSTRACT An inhaling device for medicinal powders comprising a pump and an inhaler wherein the inhaler has a cavity formed by the interconnection of two-compartments for holding a puncturable capsule containing a medici nal powder. Two sliding needles acting against the action of return springs pierce the capsule. In a preferred embodiment, the lower body portion of the inhaler is attached to the pump when in use and may be stored in at rest position when the inhaler is inverted into the pump.
22 Claims, 6 Drawing Figures r L 56o US Patent Sept. 23,1975 Sh6t 1 01 2 3,906,950
US mm Sept. 23,1975 Sheet 2' 0f 2 3,9,%
INHALING DEVICE FOR POWDERED MEDICAMENTS BACKGROUND OF THE INVENTION 1. Field of the Invention The invention relates to an inhaler for the administration of medicinal powders. More particularly, the inhaler relates to a traditional pump and an inhaler body having means for piercing a stored capsule containing medicinal powder.
2. Description of the Prior Art Inhalers are already known utilizing an elastic pump and a needle piercing a capsule which contains a me' dicinal substance; generally their working is not completely satisfactory as a result of rather complicated construction and cumbersome dimensions. In the in haler of the present invention, the above mentioned inconveniences have been practically eliminated, so that the inhaler is easily and quickly constructed and of reduced dimensions.
SUMMARY OF THE INVENTION It is the object of this invention to providean inhaler having simplified construction and reduced dimensions for use in combination with a conventional pump as an inhaling device for supplying medicinal powders to a body cavity.
It is another object to provide an inhaler having means for partial storage within the pump therefor.
It is an additional object to provide an inhaler having a means wheel to facilitate locking engagement with the pump.
It is a further object to provide an inhaler having a plurality of slidable alignment means. I
It is also an object to provide an inhaler having a spring-biased means for penetrating each end of a capsule stored therewithin.
In satisfaction of these objects and in accordance with the spirit of this invention, the inhaler contains a cavity-penetrating element. at one end thereof, through which air-entrained powder is forced out into a body cavity. a central element with an inside cavity for locating a capsule of medicinal powder therewithin. a pair of piercing devices for the endwise perforation of the capsule, and a base element having a polished surface interrupted by a ratchet wheel for connection with the pump. In more detail, the central element ofthe inhaler body is relatively fixed and formed by two components which are connected to each other, for example, by threading, bayonet insertion, and similar techniques. These components define a cavity therewithin, for placement of the capsule, and are slidably attached to a pair of relatively movable elements which hold piercing needles and which telescopically slide inside the two above-mentioned capsule holder components against the action of a pair of return springs.
The base element of the inhaler is so shaped that when the device is not in use, the inhaler body may be inverted into the pump, therby resulting in a noticeable reduction in overall size and a pleasant compact aspect of the whole which is aesthetically and practically favorable.
The inhaling device is adapted for delivering powdered substances in aerated form from a pierced capsule and comprises a pump and an inhaler, the inhaler comprising a relatively fixed central element formed by two connectable components and defining a cavity for reception of the capsule. and a pair of relatively moveable needle holder elements telescopically slidablc within the connectable components against the action of a pair of return springs. The components may be connected by screw means, a bayonet clutch means. or the like. Each of the pair of needle holder elements comprises a capsule-piercing needle. Each of the components is attached to a sleeve having an interior shoulder and each of the pair of needle holder elements has an outwardly disposed shoulder which is capable of reciprocating between a rest position against one of the interior shoulders and a ncedle-piercing position against one of the connectable components. The inhaler also comprises a nose piece and a pump piece and one of the pair of holder elements is locked by friction to the noscpiecc and the other of the pair of needle holder elements may be locked against the piece by mi cro-ribs having saw teeth.
BRIEF DESCRIPTION OF THE DRAWINGS The inhaler which constitutes the present invention is shown in the accompanying drawings of the preferred embodiment in which:
FIG. 1 represents a side elevation of the assembled inhaling device comprising the inhaler inserted in a pump in operative condition.
FIG. 2 is a side elevation similar to FIG. I with the inhaler inverted in the pump to reduce the size of the device while partially stored therewithin.
FIG. 3 is a longitudinal section through the inhaler while in uncompressed condition.
FIG. 4 is a longitudinal section of the inhaler. similar to FIG. 3 but with the inhaler in a compressed condition, while in operative combination with a pump.
FIG. 5 is a cross-section taken along lines 55 of FIG. 3, and
FIG. 6 is a side elevation of the noseward component of the cavity-forming element.
DESCRIPTION OF THE PREFERRED EMBODIMENT Referring to the drawings. the inhaler 8 of this invention is employed in combination with a conventional pump 100 and comprises a central storage unit 10 having a central cavity defined by walls 13 within which a medicinal powder-container capsule 15 is inserted as needed by unscrewing a pair of compartments 20, 30. A pair of stop sleeves 60, 70 are non-slidably attached to the unit 10 and are outside of and in sliding relation to a pair of needle holders 40, containing a pair of capsule-puncturing needles 41, 51. The pair of stop sleeves 60, is also within and in sliding relation to a pair of end pieces, the nose piece and the pump piece 90, to which the holders 40, 50 are rigidly attached. The holders 40, 50 are biased away from the central cavity by a pair of springs 25, 35.
Coaxially disposed throughout the entire inhaler of this invention are a series of central holes for passage of air which enters the inhaler from the pump through base opening 98 and air passage 58, passes through the four air passages 59 shown in FIG. 5 to central hole 32 around pump needle 51, enters and passes through the punctured capsule 15 while entraining medicinal powder therefrom. travels past nose needle 41 through central hole 22, passes through the four air passages 49 into swirl compartment 83, and exits from the inhaler through discharge hole 81 in nosepiece 80.
The unit is formed by screwably connecting the nose compartment and the base compartment 30. The compartments 20, have coaxially disposed central holes 22, 32, annularly disposed spring wells 24, 34 which open away from the capsule 15, outer cylindrical recesses with surfaces 23, 33, and connecting screw threads 29, 39 by means of which the compartments 20, 30 are connected. Nose return spring 25 is seated within spring well 24, and pump return spring is seated within spring well 34.
Nose needle holder 40 and pump needle holder have somewhat l-l-shaped cross sections and comprise. respectively, annular fixed ends 46, 56 and annular sliding ends 47, 57 which rest against the springs 25, 35 within the spring wells 24, 34, as shown in FIG. 4. The holders 40, 50 also comprise four air passages 49, 59 which are separated by four radially spaced longitudinally disposed ribs, ribs 54 only being identified in FIG. 5. Each set of ribs 44, 54 supports a central portion containing a central needle recess which opens only toward the central cavity. The butt 42 of nose needle 41 and the butt 52 of pump needle 51 are each rigidly attached within these respective central needle recesses so that the respective needle points 43, 53 are coaxially aligned, centrally disposed within the central holes 22, 32, and in puncturing relationship to the ends of the capsule 15 within the range of compressibility of the springs 25, 35.
Additionally, the holders 40, 50 respectively comprise circumannular shoulders 45, 55 which extend outwardly exactly as far as the walls 23, 33 of the sleeve recesses of each compartment 20, 30. The circular sides 48, 58 of the shoulders 45, 55, opposite to the cavity for the capsule 15, function as a stop means in cooperation with the nose sleeve 60 and the pump sleeve 70, respectively, and the outer cylindrical surfaces of the shoulders 45, 55 are in sliding contact with the inner cylindrical surfaces 61, 71 of the sleeves 60, 70, thus functioning cooperatively therewith as an alignment means.
The nose and pump sleeve 60, respectively comprise elongated cylindrical portions, having outer sides 62, 72 and inner sides 61, 71, and inwardly extending interior shoulders 65, 75, having respective cavityfacing circular surfaces 66, 76, inner cylindrical surfaces 68, 78, and endward-facing circular surfaces 67, 77. The surfaces 68, 78 function as a sliding alignment means in cooperation with the cylindrical surfaces 46a, 56a of the fixed ends 46, 56 of the needle holders 40, 50. The inner side 61, 71 are non-slidably attached to the recessed outer surfaces 23, 33 and function cooperatively with the cylindrical outer surfaces of the shoulders 45, 55 as another sliding alignment means. Nonslidable attachment may be attained by means of suitable adhesive or by circumferential knurlings of the facing surfaces such as the knurlings 26 which are indicated in FIG. 6.
The nose piece 80 comprises a tapered penetration portion 82 through which passes the central discharge hole 81 therein. a skirt portion 84 which extends toward the cavity 15, and a stepped portion 85 therebetween. An annular recess coincides with the inner edge of the step portion 85 and penetrates longitudinally into the penetration portion 82. Into this annular recess, the fixed end 46 of the nose needle holder 40 is rigidly attached. as with an adhesive. The outer surface 62 of the nose sleeve 60 is in sliding engagement with the inner surface of the skirt 84 and functions cooperatively therewith as an alignment means.
The pump piece comprises an outer rim 91, a base 92 having an inwardly projecting circular lip to define the base opening 98, a circular lug 94 spaced pumpward from the edge of the rim 91, and circumferential serrations 97 along the inner surface of the base 92 and noseward of its circular lip. The lug 94 has a circular and arcuately receding surface 95, which acts as a storage stop means when the inhaler is in its inverted storage position shown in FIG. 2, and a circular and radially extending surface 96 which acts as an operational stop means when the inhaler is inserted into a conventional pump 100, as shown in FIGS. 1, 3, and 4. The serrations 97, which may be considered as ribbings, corrugations, or knurlings, are matched and engaged by similar serrations in the surfaces 56a.
The pump 100 typically has side walls 101, a circular top edge 102 which engages the surface 96 when the inhaler 8 is in operative position, and an air-containing interior 104 which should have sufficient depth to accommodate the inhaler 8 from the surface to the tip of the penetration portion 82 when the inhaler 8 is in stored position partially within the pump 100.
In summary, the inhaler 8 comprises three pairs of slidable alignment means:
I. inner cylindrical surfaces of skirt 84 and rim 91 in sliding contact with outer cylindrical surfaces 62, 72; 2. inner cylindrical surfaces 61, 71 in sliding contact with outer cylindrical surfaces of the shoulders 45, 55; and 3. inner cylindrical surfaces 68, 78 in sliding contact with outer cylindrical surfaces 46:1, 560. Because of these three pairs of slidable alignment means, the inhaler 8 possesses a high degree of trueness so that binding and wear are minimized.
In FIGS. 1-4, the profile of the cylindrical surface of the lower body portion of the inhaler 8, which is connected by friction with a pump of suitable dimensions and configuration, is polished and uniform and interrupted by the lug 94 where circular lines of contact 95 and 96 with the cylindrical surface represent the stop points in locking engagement with the pump 100 when the inhaler 8 is ready to use and when it is in storage position, respectively.
The inhaling device operates as follows:
Initially, the inhaler 8, inverted in the pump 100 (as shown in FIG. 2 is extracted therefrom and connected by friction locking in its upright position to the pump 100. Compartment 20 is then screwed off from compartment 30 and the capsule 15 of powder is inserted therein, after which nosepiece 80 and pumppiece 90 are moved towards one another, i.e., a contraction of the inhaler is caused along arrows AB, which creates two diametrally opposed perforations in capsule 15. Compare FIG. 1 with FIG. 4. Thereafter, it is possible to press the pump 100 to provoke the passage of the powder content of the capsule into a human cavity, such as nasal cavity or other cavities of the human body.
The present invention is not to be limited to the specific embodiment having the scope and advantages described hereinbefore, for various modifications can be made without departing from the spirit of the invention which should he understood asbeihglimited onlyiby the scope of the accompanying"claimst a 1. An inhalingdeyice, for-delivering powderedsubstances in aerated form from a pierced capsule, comprisinga pumpand. an inhaler, said inhalercomprising:
A. a, relatively fixed central element formed by two connectahle components and def ini ng a cavity. for reception of said capsule, and
B. a pair of relatively movcable ncc dleiholde'r ielm ments including piercing means mounted therein, which are: i IN 4 i r H l. telescopically slidable within said'corinectable components against the action of a pair of return springs and in the path of movement of air through said inhaler,
2. disposed in mutually opposed relationship and in straddling relationship to said capsule, and
3. constituting a means for piercing said capsule when said springs are compressed by slidably moving said needle holder elements toward each other.
2. The inhaling device of claim 1 whereinsaid components are connected by screw means.
3. The inhaling device of claim 1 wherein each of said pair of needle holer elements comprises a capsulepiercing needle.
4. The inhaling device of claim 1 wherein each of said components is attached to a sleeve having an interior shoulder and each of said pair of needle holder elements has an outwardly disposed shoulder which is capable of reciprocating between a rest position against one of said interior shoulders and a needle-piercing position against one of said conncctable components.
5. The inhaling device of claim 4 wherein said inhaler comprises a nose piece and a pump piece and one of said pair of said needle holder elements is locked by friction to said nose piece and the other of said pair of needle holder elements is locked against said pump piece by micro-ribs having saw teeth.
6. An inhaler for storing, entraining, and delivering powders in aerated condition, comprising;
A. a central storage unit for said powders,
B. a pair of needle holders including piercing means mounted therein which straddle said unit and are slidably connected thereto,
C. a nose piece which is non-slidably attached to one of said pair of needle holders,
D. a pump piece which is non-slidably attached to the other of said pair of needle holders, and
E. a longitudinally disposed air passage means extending from end to end of said inhaler, through said pump piece, said pair of needle holders, said central storage unit, and said nose piece, said nose piece and said pump piece ecah being longitudinally slidable toward said central storage unit to provide opposed piercing means for the central storage unit, whereby said powders are released.
7. The inhaler of claim 6 wherein said central storage unit comprises a pair of connectable compartments which define and contain. in combination, a cavity thcrewithin for storage of a capsule containing said powder.
8. The inhaler of claim 7 wherein each of said pair of conncctable compartments comprises an annular spring well within which a compression spring is seated.
'9. T he inhaler of claim.8 wherein each of said pair of needle holderscomprises a annular sliding end which is;slidably mounted within one of said annular spring wells andinengagement-with one .Of said springs.
10. The inhaler of claim 9.which further comprises a pair of stop:slceves which straddle said. unit and are non-slidably attached thereto.
11:. The inhaler of claim 10 wherein said pair of stop sleeves is in slidably circumferential and alignmentma'intaining relation to said pair of needle holder element's. 1 I
"12.The inhaler of claim 11- wherein each of said pair of stop sleeves has a cylindrical inner wall and said needle holders comprise circumanntilar shoulders which extend outwardly into slidable and alignmentmaintaining relation with said cylindrical inner walls of said stop sleeves.
13. The inhaler of claim 12 wherein each of said pair of needle holders additionally comprises an annular fixed end, one of said fixed ends being non-slidably attached to said nose piece and the other being nonslidably attached to said pump piece.
14. The inhaler of claim 13 wherein each of said pair of needle holders comprises a capsule-piercing needle, said needles being coaxially disposed in mutually opposed relationship and in straddling relationship to said capsule and being adapted to pierce said capsule when said springs are compressed by slidably moving said nose piece and said pump piece toward each other.
15. The inhaler of claim 14 wherein each of said stop sleeves additionally comprises an inwardly extending interior shoulder which extends into sliding engagement with exterior cylindrical surfaces of said fixed ends, as a sliding alignment means.
16. The inhaler of claim 15 wherein:
A. said nosepiece, said stop sleeves, and said central storage unit have a smaller exterior diameter than the exterior diameter of said pump piece, and
B. said pump piece comprises a circumferential and outwardly extending lug having an arcuately recedingsurface and a radially receding surface,
whereby said arcuately receding surface functions as a storage stop means, when said inhaler is inverted into a pump for storage by inserting said nose piece thereinto, and said radially receding surface functions as an operational stop means, when said inhaler is inserted into said pump by engaging said pump piece therewith.
17. The inhaler of claim 16 wherein said pump piece further has an exterior cylindrical surface which is polished and uniformly interrupted by a friction locking means for the mouthpiece of said pump.
18. The inhaling device of claim 17 wherein the points of contact between the cylindrical surface of the lower body portion and the surface normal to said means are friction locking points between said inhaler and said pump.
19. The inhaling device of claim 17 wherein the points of contact between the cylindrical surface of the lower body portion and the portions of said means have curved surfaces which are stop points for friction locking between said inhaler and said pump when said inhaling device is not in use.
20. The inhaling device of claim 5 wherein:
A. said nose piece and said. pump piece each comprises a skirt portion extending toward said cavity and having an inner cylindrical surface adapted for sliding contact; and
B. each said sleeve comprises an outer cylindrical surface adapted for said sliding contact with one of said inner cylindrical surfaces of said skirt portions of said nose piece and said pump piece to form a first pair of slidable alignment means.
21. The inhaling device of claim wherein:
Apeach said sleeve, attached to one of said two conncctahle components. comprises an inner cylindrical surface adapted for sliding contact; and
B. each said outwardly disposed shoulder of said pair of needle holder elements comprises an outer cylindrical surface adapted for said sliding contact with one of said sleeves to form a second pair of slidable alignment means.
22. The inhaling device of claim 21 wherein:
A. each said interior shoulder of said sleeves attached to said two components comprises an inner cylindrical surface adapted for sliding contact: and
Bi each said needle holder element comprises an outer cylindrical surface adapted for said sliding contact with one of said inner cylindrical surfaces of said interior shoulders to form a third slidable alignment means. said first, second. and third pairs of slidable alignment means imparting a high degree of trueness to said inhaler so that binding and wear are minimized.
|Cited Patent||Filing date||Publication date||Applicant||Title|
|US2307986 *||15 Feb 1940||12 Jan 1943||Bolte||Insufflator|
|US2517482 *||9 Apr 1949||1 Aug 1950||Sharp & Dohme Inc||Inhaler|
|US2519555 *||31 Aug 1945||22 Aug 1950||Abbott Lab||Sterile medicament insufflator cartridge and insufflator|
|US2581182 *||14 Mar 1950||1 Jan 1952||Abbott Lab||Inhaler|
|US2946332 *||23 Dec 1957||26 Jul 1960||Nysco Lab Inc||Insufflator|
|US3507277 *||15 Sep 1967||21 Apr 1970||Fisons Pharmaceuticals Ltd||Inhalation device|
|US3669113 *||18 Jun 1969||13 Jun 1972||England Eunice Cockburn Howell||Inhalation device|
|Citing Patent||Filing date||Publication date||Applicant||Title|
|US4013075 *||15 Jul 1975||22 Mar 1977||I.S.F. S.P.A.||Inhalers and insufflators having a cutting means|
|US4069819 *||5 Aug 1976||24 Jan 1978||Societa Farmaceutici S.P.A.||Inhalation device|
|US4095596 *||26 Nov 1976||20 Jun 1978||Smithkline Corporation||Nasal inhaler|
|US4105027 *||26 Oct 1976||8 Aug 1978||Syntex Puerto Rico, Inc.||Inhalation device|
|US4116195 *||10 Feb 1977||26 Sep 1978||Allen & Hanburys Limited||Device for dispensing medicaments|
|US4240418 *||28 Feb 1979||23 Dec 1980||Schering Aktiengesellschaft||Apparatus for the inhalation of medicinal agents|
|US4338931 *||28 Apr 1980||13 Jul 1982||Claudio Cavazza||Device for the quick inhalation of drugs in powder form by humans suffering from asthma|
|US4446862 *||30 Oct 1980||8 May 1984||Baum Eric A||Breath actuated devices for administering powdered medicaments|
|US4620847 *||6 May 1984||4 Nov 1986||Vsesojuzny Nauchno-Issledovatelsky Institut Meditsinskikh Polimerov||Device for administering powdered substances|
|US4645487 *||5 Jun 1984||24 Feb 1987||Vsesojuzny Nauchno-Issledovatelsky Institut Meditsinskikh Polimerov||Device for administering powdered substances|
|US4884565 *||27 Jul 1988||5 Dec 1989||Miat S.P.A.||Insufflator for the administration of drugs in the form of a powder pre-dosed into opercola|
|US4889114 *||2 Jul 1987||26 Dec 1989||Boehringer Ingelheim Kg||Powdered pharmaceutical inhaler|
|US5033463 *||22 Oct 1990||23 Jul 1991||Miat S.P.A.||Multi-dose inhaler for medicaments in powder form|
|US5152284 *||24 May 1991||6 Oct 1992||Phidea S.P.A.||Disposable inhaler with pre-pierced capsule|
|US5161524 *||2 Aug 1991||10 Nov 1992||Glaxo Inc.||Dosage inhalator with air flow velocity regulating means|
|US5366122 *||27 Aug 1992||22 Nov 1994||Ing. Erich Pfeiffer Gmbh & Co. Kg||Dispenser for flowable media|
|US5388572 *||26 Oct 1993||14 Feb 1995||Tenax Corporation (A Connecticut Corp.)||Dry powder medicament inhalator having an inhalation-activated piston to aerosolize dose and deliver same|
|US5388573 *||2 Dec 1993||14 Feb 1995||Tenax Corporation||Dry powder inhalator medicament carrier|
|US5460173 *||25 Mar 1994||24 Oct 1995||Tenax Corporation||Dry powder inhaler medicament carrier|
|US5488946 *||1 Mar 1994||6 Feb 1996||Calhoun; Clifford A.||Emergency breathing device for opening cartridges|
|US5617845 *||3 May 1994||8 Apr 1997||Boehringer Ingelheim Kg||Inhalation device free from propellent gas|
|US5653191 *||29 Nov 1995||5 Aug 1997||Calhoun; Clifford A.||Pressure indicator|
|US5692496 *||1 Aug 1996||2 Dec 1997||Innovative Devices, Llc||Dry powder medicament inhalator having an inhalation-activated flow diverting means for triggering delivery of medicament|
|US5715811 *||25 May 1995||10 Feb 1998||Unisia Jecs Corporation||Inhaling type medicine administering device and using method therefor|
|US5752505 *||18 Mar 1997||19 May 1998||Unisia Jecs Corporation||Inhalation-type medicine delivery device|
|US5810004 *||9 Oct 1996||22 Sep 1998||Unisia Jecs Corporation||Medicator for a capsule filled with a powdered drug|
|US5823183 *||25 Mar 1997||20 Oct 1998||Innovative Devices||Dry powder medicament inhalator having an inhalation-activated flow diverting means for triggering delivery of medicament|
|US5901703 *||6 Feb 1995||11 May 1999||Unisia Jecs Corporation||Medicine administering device for nasal cavities|
|US5921236 *||11 Mar 1996||13 Jul 1999||Unisia Jecs Corporation||Medicine administering device for nasal cavities|
|US5988163 *||11 May 1998||23 Nov 1999||Innovative Devices||Dry powder medicament inhalator having an inhalation-activated flow diverting means for triggering delivery of delivery of medicament|
|US6013050 *||24 Apr 1997||11 Jan 2000||Powderject Research Limited||Particle delivery|
|US6048857 *||20 Jan 1998||11 Apr 2000||Ellinwood, Jr.; Everett H.||Dosing method of administering medicaments via inhalation administration|
|US6186141 *||9 May 1997||13 Feb 2001||Glaxo Wellcome Inc.||Unit dose dispensing device|
|US6209538 *||17 Mar 1998||3 Apr 2001||Robert A. Casper||Dry powder medicament inhalator having an inhalation-activated flow diverting means for triggering delivery of medicament|
|US6273086 *||28 Jan 1999||14 Aug 2001||Unisia Jecs Corporation||Inhalant medicator|
|US6341605 *||22 Jan 1999||29 Jan 2002||Unisia Jecs Corporation||Inhalant medicator|
|US6546929||4 Jun 2001||15 Apr 2003||Inhale Therapeutic Systems, Inc.||Dry powder dispersing apparatus and methods for their use|
|US6550477||27 Jan 2000||22 Apr 2003||Innovative Devices, Llc|
|US6561186||27 Nov 2001||13 May 2003||Innovative Devices|
|US6681768||21 Jun 2002||27 Jan 2004||Sofotec Gmbh & Co. Kg||Powder formulation disintegrating system and method for dry powder inhalers|
|US6705313 *||9 May 2002||16 Mar 2004||Ph&T S.P.A.||Device usable in the treatment of affections of the airways|
|US6732732||10 Oct 2002||11 May 2004||Advanced Inhalation Research, Inc.||Inhalation device and method|
|US6901929||19 Dec 2002||7 Jun 2005||Nektar Therapeutics||Dry powder dispersing apparatus and methods for their use|
|US6923178||9 May 2002||2 Aug 2005||Innovative Devices, Llc.||Medicament container with same side airflow inlet and outlet|
|US6948494||10 May 2000||27 Sep 2005||Innovative Devices, Llc.||Medicament container with same side airflow inlet and outlet and method of use|
|US6978941||9 Apr 2004||27 Dec 2005||Aerogen, Inc.||Base isolated nebulizing device and methods|
|US7032590||5 Jan 2004||25 Apr 2006||Aerogen, Inc.||Fluid filled ampoules and methods for their use in aerosolizers|
|US7032593||17 Apr 2002||25 Apr 2006||Advanced Inhalation Research, Inc.||Inhalation device and method|
|US7040549||21 Mar 2003||9 May 2006||Aerogen, Inc.||Systems and methods for controlling fluid feed to an aerosol generator|
|US7066398||30 Mar 2001||27 Jun 2006||Aerogen, Inc.||Aperture plate and methods for its construction and use|
|US7100600 *||20 Mar 2001||5 Sep 2006||Aerogen, Inc.||Fluid filled ampoules and methods for their use in aerosolizers|
|US7104463||6 Oct 2005||12 Sep 2006||Aerogen, Inc.||Base isolated nebulizing device and methods|
|US7112341||13 Apr 2000||26 Sep 2006||Nektar Therapeutics||Pulmonary administration of dry powder formulations for treating infertility|
|US7146978||5 Feb 2004||12 Dec 2006||Advanced Inhalation Research, Inc.||Inhalation device and method|
|US7163013 *||3 Oct 2002||16 Jan 2007||Alchemy Healthcare Limited||Apparatus for the nasal or oral delivery of a medicament|
|US7174888||5 Sep 2003||13 Feb 2007||Aerogen, Inc.||Liquid dispensing apparatus and methods|
|US7195011||30 Jun 2004||27 Mar 2007||Aerogen, Inc.||Convertible fluid feed system with comformable reservoir and methods|
|US7201167||14 Mar 2005||10 Apr 2007||Aerogen, Inc.||Method and composition for the treatment of lung surfactant deficiency or dysfunction|
|US7267121||30 Sep 2004||11 Sep 2007||Aerogen, Inc.||Aerosol delivery apparatus and method for pressure-assisted breathing systems|
|US7278425||5 Feb 2004||9 Oct 2007||Alkermes, Inc.||Inhalation device and method|
|US7290541||30 Jun 2004||6 Nov 2007||Aerogen, Inc.||Aerosol delivery apparatus and method for pressure-assisted breathing systems|
|US7318436||25 Oct 2004||15 Jan 2008||Innovative Devices, Llc||Medicament container with same side airflow inlet and outlet and method of use|
|US7322349||18 Jun 2003||29 Jan 2008||Aerogen, Inc.||Apparatus and methods for the delivery of medicaments to the respiratory system|
|US7331339||23 Nov 2004||19 Feb 2008||Aerogen, Inc.||Methods and systems for operating an aerosol generator|
|US7353823 *||13 May 2003||8 Apr 2008||Bioactis Limited||Powder chemical feeding device for nasal cavity|
|US7360536||7 Jan 2003||22 Apr 2008||Aerogen, Inc.||Devices and methods for nebulizing fluids for inhalation|
|US7422013||9 Mar 2005||9 Sep 2008||Nektar Therapeutics||Dry powder dispersing apparatus and methods for their use|
|US7464706||4 Sep 2003||16 Dec 2008||Mannkind Corporation||Unit dose cartridge and dry powder inhaler|
|US7559325||9 Apr 2004||14 Jul 2009||Novartis Pharma Ag||Aerosolization apparatus with air inlet shield|
|US7600511||30 Oct 2002||13 Oct 2009||Novartis Pharma Ag||Apparatus and methods for delivery of medicament to a respiratory system|
|US7611709||2 May 2005||3 Nov 2009||Boehringer Ingelheim Pharma Gmbh And Co. Kg||1,4 O-linked saccharose derivatives for stabilization of antibodies or antibody derivatives|
|US7628339||5 May 2006||8 Dec 2009||Novartis Pharma Ag||Systems and methods for controlling fluid feed to an aerosol generator|
|US7648960||21 Nov 2003||19 Jan 2010||Mannkind Corporation||Method for delivery of monomeric or dimeric insulin complexed to diketopiperazine microparticles|
|US7669597||15 May 2008||2 Mar 2010||Mystic Pharmaceuticals, Inc.||Combination unit dose dispensing containers|
|US7677467||20 Apr 2005||16 Mar 2010||Novartis Pharma Ag||Methods and devices for aerosolizing medicament|
|US7713929||2 Apr 2007||11 May 2010||Biodel Inc.||Rapid acting and long acting insulin combination formulations|
|US7718609||11 Apr 2007||18 May 2010||Biodel Inc.||Rapid acting and long acting insulin combination formulations|
|US7723306||2 May 2005||25 May 2010||Boehringer Ingelheim Pharma Gmbh & Co. Kg||Spray-dried powder comprising at least one 1,4 O-linked saccharose-derivative and methods for their preparation|
|US7727962||2 May 2005||1 Jun 2010||Boehringer Ingelheim Pharma Gmbh & Co. Kg||Powder comprising new compositions of oligosaccharides and methods for their preparation|
|US7748377||30 Oct 2007||6 Jul 2010||Novartis Ag||Methods and systems for operating an aerosol generator|
|US7771642||1 Apr 2005||10 Aug 2010||Novartis Ag||Methods of making an apparatus for providing aerosol for medical treatment|
|US7806117 *||7 Jun 2006||5 Oct 2010||Shin Nippon Biomedical Laboratories, Ltd.||Peroral powder delivery device|
|US7943178||10 Dec 2009||17 May 2011||Mannkind Corporation||Methods and compositions for delivering peptides|
|US7946291||20 Apr 2004||24 May 2011||Novartis Ag||Ventilation systems and methods employing aerosol generators|
|US7963089||15 Sep 2008||21 Jun 2011||Mystic Pharmaceuticals, Inc.||Deep draw container forming method|
|US7971588||24 Mar 2005||5 Jul 2011||Novartis Ag||Methods and systems for operating an aerosol generator|
|US8006695||10 Nov 2005||30 Aug 2011||Cipla Limited||Inhaler|
|US8069851||22 Jun 2009||6 Dec 2011||Novartis Ag||Aeorosolization apparatus with air inlet shield|
|US8084420||26 Nov 2008||27 Dec 2011||Biodel Inc.||Rapid acting and long acting insulin combination formulations|
|US8156936||2 Nov 2007||17 Apr 2012||Mannkind Corporation||Unit dose capsules and dry powder inhaler|
|US8161969||21 Mar 2008||24 Apr 2012||Novartis Ag||Dry powder dispersing apparatus and methods for their use|
|US8196573||23 Jan 2008||12 Jun 2012||Novartis Ag||Methods and systems for operating an aerosol generator|
|US8215300||14 Apr 2008||10 Jul 2012||Mannkind Corporation||Unit dose cartridge and dry powder inhaler|
|US8336545||16 Jan 2007||25 Dec 2012||Novartis Pharma Ag||Methods and systems for operating an aerosol generator|
|US8357696||28 Jan 2010||22 Jan 2013||Mpex Pharmaceuticals, Inc.||Aerosolized fluoroquinolones and uses thereof|
|US8377009||9 Jan 2008||19 Feb 2013||Mystic Pharmaceuticals, Inc.||Intranasal cartridge devices|
|US8389470||5 Jan 2011||5 Mar 2013||Mannkind Corporation||Methods and compositions for delivering peptides|
|US8394414||12 Nov 2003||12 Mar 2013||Mannkind Corporation||Method for drug delivery to the pulmonary system|
|US8398001||19 Jun 2006||19 Mar 2013||Novartis Ag||Aperture plate and methods for its construction and use|
|US8496002||10 Jun 2008||30 Jul 2013||Civitas Therapeutics, Inc.||Powder inhaler devices|
|US8501240||23 Dec 2008||6 Aug 2013||Novartis Ag||Compositions comprising an active agent|
|US8522775 *||15 Jun 2007||3 Sep 2013||Cipla Limited||Dry powder inhaler|
|US8524734||22 Oct 2009||3 Sep 2013||Mpex Pharmaceuticals, Inc.||Aerosolized fluoroquinolones and uses thereof|
|US8524735||22 Oct 2009||3 Sep 2013||Mpex Pharmaceuticals, Inc.||Aerosolized fluoroquinolones and uses thereof|
|US8539944||8 Apr 2008||24 Sep 2013||Novartis Ag||Devices and methods for nebulizing fluids for inhalation|
|US8539946||19 Feb 2007||24 Sep 2013||Eric Zembrod||Dry powder inhaler|
|US8546423||22 Oct 2009||1 Oct 2013||Mpex Pharmaceuticals, Inc.||Aerosolized fluoroquinolones and uses thereof|
|US8561604||12 Feb 2007||22 Oct 2013||Novartis Ag||Liquid dispensing apparatus and methods|
|US8561609||7 Dec 2011||22 Oct 2013||Respira Therapeutics, Inc.||Dry powder inhaler|
|US8584669||11 Apr 2007||19 Nov 2013||Boehringer Ingelheim International Gmbh||Inhaler|
|US8616195||27 Apr 2004||31 Dec 2013||Novartis Ag||Nebuliser for the production of aerosolized medication|
|US8623817||17 Jan 2012||7 Jan 2014||Mannkind Corporation||Method of treating diabetes type 2 by administering ultrarapid acting insulin|
|US8629139||6 Oct 2009||14 Jan 2014||Mpex Pharmaceuticals, Inc.||Topical use of Levofloxacin for reducing lung inflammation|
|US8651104||11 May 2012||18 Feb 2014||Respira Therapeutics, Inc.||Bead-containing dry powder inhaler|
|US8664187||24 Feb 2012||4 Mar 2014||Novartis Ag||Methods of treatment of endobronchial infections|
|US8671937||15 Mar 2012||18 Mar 2014||Mannkind Corporation||Unit dose capsules and dry powder inhaler|
|US8673360||5 Aug 2005||18 Mar 2014||Shin Nippon Biomedical Laboratories, Ltd.||Compositions that enable rapid-acting and highly absorptive intranasal administration|
|US8683995||15 Sep 2011||1 Apr 2014||Mystic Pharmaceuticals, Inc.||Dose dispensing containers|
|US8715623||31 Oct 2007||6 May 2014||Novartis Ag||Pulmonary delivery of aminoglycoside|
|US8785396||9 Nov 2011||22 Jul 2014||Mannkind Corporation||Method and composition for treating migraines|
|US8815838||6 Oct 2009||26 Aug 2014||David C. Griffith||Aerosol fluoroquinolone formulations for improved pharmacokinetics|
|US8827946||2 Aug 2010||9 Sep 2014||Shin Nippon Biomedical Laboratories, Ltd.||Intranasal granisetron and nasal applicator|
|US8869794 *||9 Apr 2004||28 Oct 2014||Novartis Pharma Ag||Aerosolization apparatus with capsule puncturing member|
|US8875704||9 May 2014||4 Nov 2014||Optinose As||Nasal administration|
|US8889099||30 Jan 2013||18 Nov 2014||Mannkind Corporation||Methods and compositions for delivering peptides|
|US8919342||31 Jul 2008||30 Dec 2014||Boehringer Ingelheim International Gmbh||Inhaler|
|US8933023||15 Jan 2014||13 Jan 2015||Biodel Inc.||Rapid acting injectable insulin compositions|
|US8950397||6 Jun 2012||10 Feb 2015||Mannkind Corporation||Unit dose cartridge and dry powder inhaler|
|US9006175||10 Jan 2006||14 Apr 2015||Mannkind Corporation||Potentiation of glucose elimination|
|US9060927||3 Mar 2009||23 Jun 2015||Biodel Inc.||Insulin formulations for rapid uptake|
|US9061111||29 Feb 2012||23 Jun 2015||Mannkind Corporation||Unit dose capsules and dry powder inhaler|
|US9101539||14 May 2010||11 Aug 2015||Shin Nippon Biomedical Laboratories, Ltd.||Intranasal pharmaceutical compositions with improved pharmacokinetics|
|US9108211||17 Apr 2006||18 Aug 2015||Nektar Therapeutics||Vibration systems and methods|
|US9125998||14 Jan 2009||8 Sep 2015||Vectura Delivery Devices Limited||Inhaler|
|US9138410||14 Mar 2013||22 Sep 2015||Shin Nippon Biomedical Laboratories, Ltd.||Compositions for nasal administration of pharmaceuticals|
|US9192675||30 Jul 2013||24 Nov 2015||Mankind Corporation||Dry powder inhaler and system for drug delivery|
|US9220687||7 Nov 2014||29 Dec 2015||Mannkind Corporation||Substituted diketopiperazine analogs for use as drug delivery agents|
|US9233159||24 Oct 2012||12 Jan 2016||Mannkind Corporation||Methods and compositions for treating pain|
|US9241903||15 Jul 2013||26 Jan 2016||Mannkind Corporation||Method for improving the pharmaceutic properties of microparticles comprising diketopiperazine and an active agent|
|US9248076||1 Apr 2014||2 Feb 2016||Mystic Pharmaceuticals, Inc.||Dose dispensing containers|
|US9283193||10 Apr 2014||15 Mar 2016||Mannkind Corporation||Method of drug formulation based on increasing the affinity of crystalline microparticle surfaces for active agents|
|US9326936||17 Jul 2014||3 May 2016||Raptor Pharmaceuticals, Inc.||Aerosol fluoroquinolone formulations for improved pharmacokinetics|
|US9339615||14 Mar 2013||17 May 2016||Mannkind Corporation||Dry powder inhaler and system for drug delivery|
|US9346766||30 Apr 2014||24 May 2016||Mannkind Corporation||Catalysis of diketopiperazine synthesis|
|US9364436||18 Jun 2012||14 Jun 2016||Mannkind Corporation||High capacity diketopiperazine microparticles and methods|
|US9364619||19 Jun 2009||14 Jun 2016||Mannkind Corporation||Interactive apparatus and method for real-time profiling of inhalation efforts|
|US9421166||8 Apr 2014||23 Aug 2016||Novartis Ag||Pulmonary delivery of aminoglycoside|
|US9446001||22 Jun 2015||20 Sep 2016||Mannkind Corporation||Increasing drug affinity for crystalline microparticle surfaces|
|US9446133||21 Oct 2014||20 Sep 2016||Mannkind Corporation||Dry powder inhaler and system for drug delivery|
|US9492625||12 Nov 2010||15 Nov 2016||Stc.Unm||Dry powder inhaler with flutter dispersion member|
|US9511198||27 Nov 2013||6 Dec 2016||Mannkind Corporation||Dry powder inhaler and system for drug delivery|
|US9550036||3 Sep 2013||24 Jan 2017||Impel Neuropharma Inc.||Nasal drug delivery device|
|US9592354||26 Jul 2011||14 Mar 2017||Mystic Pharmaceuticals, Inc.||Combination unit dose dispensing containers|
|US9610351||13 Feb 2015||4 Apr 2017||Mannkind Corporation||Methods and compositions for treating pain|
|US9630930||11 Apr 2014||25 Apr 2017||Mannkind Corporation||Diketopiperazine microparticles with defined specific surface areas|
|US9649456 *||7 Apr 2008||16 May 2017||Optinose As||Nasal administration|
|US9655850||18 Nov 2015||23 May 2017||Mannkind Corporation||Substituted diketopiperazine analogs for use as drug delivery agents|
|US9662461||2 May 2016||30 May 2017||Mannkind Corporation||Dry powder drug delivery system and methods|
|US9675674||8 Jan 2016||13 Jun 2017||Mannkind Corporation||Diketopiperazine salts for drug delivery and related methods|
|US9682153||20 Mar 2015||20 Jun 2017||Nektar Therapeutics||Polymer conjugates of therapeutic peptides|
|US9700564||5 Mar 2012||11 Jul 2017||Horizon Orphan Llc||Use of aerosolized levofloxacin for treating cystic fibrosis|
|US9700690||12 Jun 2014||11 Jul 2017||Mannkind Corporation||Inhalation apparatus|
|US9706944||24 Mar 2015||18 Jul 2017||Mannkind Corporation||Apparatus and method for simulating inhalation efforts|
|US9717689||5 Feb 2016||1 Aug 2017||Mannkind Corporation||Method of drug formulation based on increasing the affinity of crystalline microparticle surfaces for active agents|
|US9717738||18 Apr 2016||1 Aug 2017||Horizon Orphan Llc||Aerosol fluoroquinolone formulations for improved pharmacokinetics|
|US9757395||8 Mar 2013||12 Sep 2017||Otitopic Inc.||Dry powder inhaler and methods of use|
|US9757529||15 Mar 2013||12 Sep 2017||Otitopic Inc.||Dry powder inhaler and methods of use|
|US9796688||12 Apr 2016||24 Oct 2017||Mannkind Corporation||Catalysis of diketopiperazine synthesis|
|US9801925||5 Mar 2015||31 Oct 2017||Mannkind Corporation||Potentiation of glucose elimination|
|US9802012||12 Jul 2013||31 Oct 2017||Mannkind Corporation||Dry powder drug delivery system and methods|
|US20010029947 *||6 Dec 2000||18 Oct 2001||Steve Paboojian||Receptacles to facilitate the extraction of powders|
|US20020134382 *||9 May 2002||26 Sep 2002||Snow John M.||Medicament container with same side airflow inlet and outlet and method of use|
|US20030131847 *||9 May 2002||17 Jul 2003||Fabrizio Niccolai||Device usable in the treatment of affections of the airways|
|US20030150454 *||14 Nov 2002||14 Aug 2003||Inhale Therapeutic Systems, Inc.||Aerosolization apparatus with removable mouthpiece|
|US20030209243 *||19 Dec 2002||13 Nov 2003||Inhale Therapeutic Systems||Dry powder dispersing apparatus and methods for their use|
|US20040077528 *||21 Nov 2003||22 Apr 2004||Mannkind Corporation||Purification and stabilization of peptide and protein pharmaceutical agents|
|US20040096403 *||12 Nov 2003||20 May 2004||Mannkind Corporation||Method for drug delivery to the pulmonary system|
|US20040154618 *||5 Feb 2004||12 Aug 2004||Advanced Inhalation Research, Inc.||Inhalation device and method|
|US20040154619 *||5 Feb 2004||12 Aug 2004||Advanced Inhalation Research, Inc.||Inhalation device and method|
|US20040182387 *||4 Sep 2003||23 Sep 2004||Mannkind Corporation||Unit dose cartridge and dry powder inhaler|
|US20040206350 *||14 Nov 2003||21 Oct 2004||Nektar Therapeutics||Aerosolization apparatus with non-circular aerosolization chamber|
|US20040216738 *||5 Feb 2004||4 Nov 2004||Advanced Inhalation Research, Inc.||Inhalation device and method|
|US20050028813 *||3 Oct 2002||10 Feb 2005||Ian Harrison||Apparatus for the nasal or oral delivery of a medicament|
|US20050056281 *||25 Oct 2004||17 Mar 2005||Snow John M.||Medicament container with same side airflow inlet and outlet and method of use|
|US20050088617 *||27 Oct 2003||28 Apr 2005||Jen-Chuen Hsieh||Method and apparatus for visual drive control|
|US20050150492 *||9 Apr 2004||14 Jul 2005||Nektar Therapeutics||Aerosolization apparatus with air inlet shield|
|US20050153874 *||10 Jan 2005||14 Jul 2005||Mannkind Corporation||Method of reducing serum proinsulin levels in type 2 diabetics|
|US20050177095 *||13 May 2003||11 Aug 2005||Tatsuo Tsutsui||Powder chemical feeding device for nasal cavity|
|US20050186146 *||14 Feb 2005||25 Aug 2005||Nektar Therapeutics||Interleukin-13 antagonist powders, spray-dried particles, and methods|
|US20050250704 *||2 May 2005||10 Nov 2005||Boehringer Ingelheim Pharma Gmbh & Co. Kg||Powder comprising new compositions of oligosaccharides and methods for their preparation|
|US20050250705 *||2 May 2005||10 Nov 2005||Boehringer Ingelheim Pharma Gmbh Co. Kg||Spray-dried powder comprising at least one 1,4 O-linked saccharose-derivative and methods for their preparation|
|US20050255119 *||2 May 2005||17 Nov 2005||Boehringer Ingelheim Pharma Gmbh & Co. Kg||1,4 O-linked saccharose derivatives for stabilization of antibodies or antibody derivatives|
|US20060283448 *||30 Aug 2006||21 Dec 2006||Advanced Inhalation Research, Inc.||Inhalation device and method|
|US20070020191 *||10 Jan 2006||25 Jan 2007||Mannkind Corporation||Potentiation of glucose elimination|
|US20070023547 *||19 Jun 2006||1 Feb 2007||Aerogen, Inc.||Aperture plate and methods for its construction and use|
|US20070051362 *||25 Apr 2005||8 Mar 2007||Sullivan Timothy R||Multiple unit dose drug delivery system|
|US20070086952 *||29 Sep 2006||19 Apr 2007||Biodel, Inc.||Rapid Acting and Prolonged Acting Inhalable Insulin Preparations|
|US20070209659 *||12 Feb 2007||13 Sep 2007||Aerogen, Inc.||Liquid dispensing apparatus and methods|
|US20070283955 *||7 Jun 2006||13 Dec 2007||Bioactis Limites||Peroral powder delivery device|
|US20080039368 *||11 Apr 2007||14 Feb 2008||Biodel Inc.||Rapid acting and long acting insulin combination formulations|
|US20080053437 *||2 Nov 2007||6 Mar 2008||Mannkind Corporation||Unit dose capsules and dry powder inhaler|
|US20080063606 *||31 Oct 2007||13 Mar 2008||Tarara Thomas E||Pulmonary delivery of aminoglycoside|
|US20080090753 *||9 Oct 2007||17 Apr 2008||Biodel, Inc.||Rapid Acting Injectable Insulin Compositions|
|US20080105256 *||10 Nov 2005||8 May 2008||Cipla Limited||Inhaler|
|US20080177246 *||9 Jan 2008||24 Jul 2008||First City Tower||Intranasal Cartridge Devices|
|US20080190425 *||14 Apr 2008||14 Aug 2008||Steiner Solomon S||Unit dose cartridge and dry powder inhaler|
|US20080230058 *||21 Mar 2008||25 Sep 2008||Nektar Therapeutics||Dry powder dispersing apparatus and methods for their use|
|US20080248999 *||3 Apr 2008||9 Oct 2008||Biodel Inc.||Amylin formulations|
|US20090025721 *||10 Jun 2008||29 Jan 2009||Alkermes, Inc.||Powder inhaler devices|
|US20090071108 *||15 Sep 2008||19 Mar 2009||Mystic Pharmaceuticals, Inc.||Deep draw container forming method|
|US20090090433 *||13 Apr 2006||9 Apr 2009||Symyx Technologies Europe Sa||Apparatus And Method For Storing And Dispensing Material, Especially In Micro Quantities And In Combination With Limited Starting Amounts|
|US20090117193 *||23 Dec 2008||7 May 2009||Nektar Therapeutics||Compositions Comprising an Active Agent|
|US20090137455 *||26 Nov 2008||28 May 2009||Biodel Inc.||Rapid acting and long acting insulin combination formulations|
|US20090175840 *||5 Jan 2009||9 Jul 2009||Biodel, Inc.||Insulin formulations for insulin release as a function of tissue glucose levels|
|US20090192075 *||25 Mar 2009||30 Jul 2009||Biodel Inc.||Amylin Formulations|
|US20090194105 *||11 Apr 2007||6 Aug 2009||Jens Besseler||Inhaler|
|US20090241949 *||27 Mar 2009||1 Oct 2009||Smutney Chad C||Dry powder inhalation system|
|US20090260623 *||22 Jun 2009||22 Oct 2009||Novartis Pharma Ag||Aeorosolization apparatus with air inlet shield|
|US20090320838 *||15 Jun 2007||31 Dec 2009||Cipla Limited||Dry powder inhaler|
|US20100086609 *||10 Dec 2009||8 Apr 2010||Mannkind Corporation||Methods and Compositions for Delivering Peptides|
|US20100287884 *||23 Oct 2008||18 Nov 2010||Sangita Seshadri||Powder conditioning of unit dose drug packages|
|US20100288275 *||7 Apr 2008||18 Nov 2010||Optinose As||Nasal administration|
|US20100313886 *||31 Jul 2008||16 Dec 2010||Herbert Wachtel||Inhaler|
|US20110033544 *||14 May 2010||10 Feb 2011||Shin Nippon Biomedical Laboratories, Ltd.||Intranasal pharmaceutical compositions with improved pharmacokinetcs|
|US20110045088 *||2 Aug 2010||24 Feb 2011||Shin Nippon Biomedical Laboratories, Ltd.||Intranasal granisetron and nasal applicator|
|US20110056488 *||14 Jan 2009||10 Mar 2011||Vectura Delivery Devices Limited||Inhaler|
|US20110105391 *||5 Jan 2011||5 May 2011||Mannkind Corporation||Methods and Compositions for Delivering Peptides|
|US20110120463 *||19 Feb 2007||26 May 2011||Victor Esteve||Dry powder inhaler|
|US20110171312 *||17 Sep 2009||14 Jul 2011||Nektar Therapeutics||Modified therapeutic peptides, methods of their preparation and use|
|US20110183901 *||31 Mar 2011||28 Jul 2011||Mannkind Corporation||Superior Control of Blood Glucose in Diabetes Treatment|
|US20130327327 *||6 Jun 2013||12 Dec 2013||Aerodesigns, Inc.||Aerosol dispenser with replaceable cartridge|
|USD748242||11 Jul 2014||26 Jan 2016||H. Stuart Campbell||Inhaler mouthpiece|
|USD752204||10 Mar 2014||22 Mar 2016||Civitas Therapeutics, Inc.||Indicator for an inhaler|
|USD752734||10 Mar 2014||29 Mar 2016||Civitas Therapeutics, Inc.||Inhaler grip|
|USD755367||10 Mar 2014||3 May 2016||Civitas Therapeutics, Inc.||Indicator for an inhaler|
|USRE45404||27 Mar 2003||3 Mar 2015||Shin Nippon Biomedical Laboratories, Ltd.||Powder medicine applicator for nasal cavity|
|CN101389367B||19 Feb 2007||5 Oct 2011||阿哈塑料技术有限公司||干粉吸入器|
|CN101815552B||31 Jul 2008||6 Mar 2013||贝林格尔.英格海姆国际有限公司||吸入器|
|EP0761248A1 *||11 Mar 1996||12 Mar 1997||Unisia Jecs Corporation||Intranasal medicator|
|EP0761248A4 *||11 Mar 1996||23 Dec 1998||Unisia Jecs Corp||Intranasal medicator|
|EP1108439A3 *||15 Dec 2000||10 Sep 2003||Ing. Erich Pfeiffer GmbH||Product dispenser|
|EP2594272A2||18 May 2006||22 May 2013||Mpex Pharmaceuticals, Inc.||Aerosolized fluoroquinolones and uses thereof|
|EP3012258A1||23 Jun 2011||27 Apr 2016||Gilead Sciences, Inc.||Pyrazolo[1,5-a]pyrimidines and -triazines as antiviral agents|
|EP3210993A1||11 Mar 2013||30 Aug 2017||Gilead Sciences, Inc.||2'- substituted carba-nucleoside analogs for antiviral treatment|
|WO1996012513A1 *||20 Oct 1995||2 May 1996||Oxford Biosciences Limited||Particle delivery|
|WO1998058695A1 *||23 Jun 1997||30 Dec 1998||Marco Cecchini||Inhaling device|
|WO2006051300A1||10 Nov 2005||18 May 2006||Cipla Limited||Inhaler|
|WO2007098870A1 *||19 Feb 2007||7 Sep 2007||Aha Kunststofftechnik Gmbh||Dry powder inhaler|
|WO2011163518A1||23 Jun 2011||29 Dec 2011||Gilead Sciences, Inc.||Pyrazolo [1, 5 -a] pyrimidines as antiviral agents|
|WO2012012776A1||22 Jul 2011||26 Jan 2012||Gilead Sciences, Inc.||Methods and compounds for treating paramyxoviridae virus infections|
|WO2012037038A1||12 Sep 2011||22 Mar 2012||Gilead Sciences, Inc.||2' -fluoro substituted carba-nucleoside analogs for antiviral treatment|
|WO2013016784A1||4 Aug 2011||7 Feb 2013||Victor Esteve||Dry powder inhaler|
|WO2013016787A1||21 Dec 2011||7 Feb 2013||Victor Esteve||Powder inhaler|
|WO2013158776A1||17 Apr 2013||24 Oct 2013||Gilead Sciences, Inc.||Compounds and methods for antiviral treatment|
|WO2015006838A1||16 Jul 2013||22 Jan 2015||Victor Esteve||Powder inhaler|
|WO2016018697A1||22 Jul 2015||4 Feb 2016||Gilead Sciences, Inc.||Thieno [3,2-d] pyrimidine, furo [3,2,d] pyrimidine, and pyrrolo [3,2-d] pyrimidines useful for treating respiratory syncitial virus infections|
|WO2017094027A1 *||1 Dec 2016||8 Jun 2017||Cipla Limited||Nasal spray assembly|
|U.S. Classification||128/203.15, 128/203.21|
|International Classification||A61M15/00, A61M13/00|
|Cooperative Classification||A61M2015/0033, A61M15/0028, A61M2202/064|